Adjuvant dexamethasone (D)+/- thalidomide (T) improves hematologic and organ responses after risk-adapted high-dose melphalan with autologous stem cell transplant (SCT) for patients with systemic AL amyloidosis (AL) Meeting Abstract


Authors: Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Nimer, S. D.; Comenzo, R. L.
Abstract Title: Adjuvant dexamethasone (D)+/- thalidomide (T) improves hematologic and organ responses after risk-adapted high-dose melphalan with autologous stem cell transplant (SCT) for patients with systemic AL amyloidosis (AL)
Meeting Title: 47th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 106
Issue: 11 Pt. 1
Meeting Dates: 2005 Dec 10-13
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2005-11-01
Start Page: 340A
Language: English
ACCESSION: WOS:000233426002098
PROVIDER: wos
PUBMED: 16342400
DOI: 10.1182/blood.V106.11.1163.1163
Notes: --- - Meeting Abstract: 1163 - 47th Annual Meeting of the American-Society-of-Hematology - DEC 10-13, 2005 - Atlanta, GA - Part 1 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Julie T Feldstein
    297 Feldstein
  2. Adam D Cohen
    44 Cohen
  3. Raymond L Comenzo
    115 Comenzo
  4. Ping Zhou
    45 Zhou
  5. Hani Hassoun
    329 Hassoun
  6. Stephen D Nimer
    347 Nimer
  7. Martin Fleisher
    312 Fleisher
  8. Lilian M Reich
    99 Reich
  9. Daniel A Filippa
    148 Filippa
Related MSK Work